Form 4: BIO-TECHNE Director Reports Stock Transaction
Insider Transaction (Form 4)
Robert Baumgartner V, a Director of BIO-TECHNE Corp, reported multiple transactions in common stock on September 22, 2026.
Summary
- Option exercise/conversion: acquired 15,940 Common Stock on September 22, 2026; holds 62,443 after (Direct).
- Tax/exercise-price withholding: disposed of 5,559 Common Stock at $72.55 ($403,305) on September 22, 2026; holds 56,884 after (Direct).
- Option exercise/conversion: disposed of 15,940 Stock Options (Right to Buy) on September 22, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Robert Baumgartner V — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-22 | Option exercise/conversion | Common Stock | 15,940 | — | — | 62,443 |
| 2026-09-22 | Tax/exercise-price withholding | Common Stock | 5,559 | $73 | $403.3K | 56,884 |
| 2026-09-22 | Option exercise/conversion | Stock Options (Right to Buy) | 15,940 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-22 | Option exercise/conversion (15,940 shares) |
| 2026-09-22 | Tax/exercise-price withholding (5,559 shares) |
| 2026-09-22 | Option exercise/conversion (15,940 shares) |
Keywords
insider transaction, Form 4, TECH, BIO-TECHNE Corp, neutral, Robert Baumgartner V
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.